Case Report: Clinical Characteristics and Outcomes of HIV Positive Patients With Metastatic Prostate Cancer Treated With Immunotherapy: A Case Series and Literature Review

BACKGROUND: The treatment of metastatic prostate cancer has been revolutionized with the advent of many targeted therapies, including immunotherapy. Pembrolizumab has demonstrated benefit in the treatment of certain patients with docetaxel-refractory metastatic castrate-resistant prostate cancer (mC...

Descripción completa

Detalles Bibliográficos
Autores principales: Idossa, Dame, Friedlander, Terence, Paller, Channing J., Ryan, Charles J., Borno, Hala T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301521/
https://www.ncbi.nlm.nih.gov/pubmed/35875156
http://dx.doi.org/10.3389/fonc.2022.910115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301521/
https://www.ncbi.nlm.nih.gov/pubmed/35875156
http://dx.doi.org/10.3389/fonc.2022.910115

Ejemplares similares